Current NDC auxiliary source row compounder:2177

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 81483-0054
Product Ndc: 81483-0054
Product Ndc Digits: 814830054
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Tirzepatide
Proprietary Name Suffix: [empty]
Nonproprietary Name: Tirzepatide
Dosage Form Name: INJECTION
Route Name: SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Tailstorm Health INC
Establishment Name: Tailstorm Health INC
Establishment Fei: [empty]
Substance Name: TIRZEPATIDE
Active Ingredients Info: 12.5 mg/.25 mL
History Active Ingredients Raw: TIRZEPATIDE
History Active Ingredients Info Raw: 12.5 mg/.25 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 81483-0054-4
Package Ndc: 81483-0054-4
Package Ndc Digits: 8148300544
Package Ndc11: 81483005404
Package Description: 4 SYRINGE, GLASS in 1 TRAY (81483-0054-4) > .25 mL in 1 SYRINGE, GLASS (81483-0054-1)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2177
Source Row Number: 2177
Source Row Hash: 537b06f9de285f4ee7a75f42797b2e9f98587c0ff23fda8c400c53ae48a5568b
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "81483-0054",
    "DEASCHEDULE": "",
    "LABELERNAME": "Tailstorm Health INC",
    "SUBSTANCENAME": "TIRZEPATIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "81483-0054-4",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Tirzepatide",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Tirzepatide",
    "PACKAGEDESCRIPTION": "4 SYRINGE, GLASS in 1 TRAY (81483-0054-4)  > .25 mL in 1 SYRINGE, GLASS (81483-0054-1) ",
    "ACTIVEINGREDIENTSINFO": "12.5 mg/.25 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2177
Source Row Number: 2177
Status Scope: package
Lookup Ndc: 81483-0054-4
Lookup Ndc Digits: 8148300544
Product Ndc: 81483-0054
Product Ndc Digits: 814830054
Package Ndc: 81483-0054-4
Package Ndc Digits: 8148300544
Package Ndc11: 81483005404
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 537b06f9de285f4ee7a75f42797b2e9f98587c0ff23fda8c400c53ae48a5568b
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01